Article
Cardiac & Cardiovascular Systems
Derek S. Chew, Mahmood Zarrabi, Isabelle You, James Morton, Aaron Low, Lucy Reyes, Brian Yuen, Glen L. Sumner, Satish R. Raj, Derek Exner, Stephen B. Wilton
Summary: This study demonstrates that remote monitoring (RM) of cardiac implantable electronic devices is associated with lower risk of death and cardiovascular hospitalization, and can lead to cost savings. Therefore, the wider implementation of this technology can improve patient outcomes and enhance health system efficiency.
CANADIAN JOURNAL OF CARDIOLOGY
(2022)
Article
Health Care Sciences & Services
Rik Stoevelaar, Arianne Stoppelenburg, Rozemarijn L. van Bruchem-Visser, Anne Geert van Driel, Dominic A. M. J. Theuns, Martine E. Lokker, Rohit E. Bhagwandien, Agnes van der Heide, Judith A. C. Rietjens
Summary: There is limited discussion of implantable cardioverter defibrillator deactivation among patients in their last phase of life. Lack of understanding of device functioning and perceived lack of time from healthcare professionals are common barriers to advance care planning. Device shocks were distressing for both patients and relatives, and relatives of patients with a deactivated device reported a higher quality of death compared to those with an active device.
PALLIATIVE MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Xijuan Guo, Connor Tripp, Nichelle L. Huber, Cuihong Hou, Rong Lv, Jing Li, Tao Liang, Samuel F. Sears
Summary: This study aimed to examine device related experiences and health related quality of life (HRQOL) in Chinese ICD patients. The results showed that HRQOL outcomes in ICD patients were generally lower compared to the Chinese general population and heart failure patients, and were influenced by multiple medical and psychosocial factors.
Article
Cardiac & Cardiovascular Systems
Zack Dale, Lana Al-Rashdan, Miriam Elman, Pranav Chandrashekar, Stephen B. Heitner, Babak Nazer, Ahmad Masri
Summary: This study reports on the mode of death and outcomes with implantable cardioverter defibrillators (ICDs) in patients with transthyretin cardiac amyloidosis (ATTR-CM). The study found that patients with ATTR-CM and primary prevention ICD infrequently receive appropriate device therapy without differing in mode of death, which was mainly related to progressive heart failure, compared to those without ICD.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Marta Jagosz, Ewa Jedrzejczyk-Patej, Wiktoria Kowalska, Michal Mazurek, Szymon Warwas, Dominika Wiktor, Adam Sokal, Oskar Kowalski, Radostaw Lenarczyk, Beata Sredniawa, Zbigniew Kalarus
Summary: The study found that there were no significant differences in quality of life after device implantation between patients with subcutaneous and conventional implantable cardioverter-defibrillators.
KARDIOLOGIA POLSKA
(2022)
Review
Cardiac & Cardiovascular Systems
Johanna B. Tonko, Christopher A. Rinaldi
Summary: Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of cardiac diseases. However, there is a need for alternative ICD configurations due to expanding patient groups and increasing complications associated with traditional devices.
Article
Cardiac & Cardiovascular Systems
Sem Briongos-Figuero, Arcadio Garcia-Alberola, Jeronimo Rubio, Jose Maria Segura, Anibal Rodriguez, Rafael Peinado, Javier Alzueta, Jose B. Martinez-Ferrer, Xavier Vinolas, Joaquin Fernandez de la Concha, Ignasi Anguera, Maria Martin, Laia Cerda, Luisa Perez
Summary: Large-scale studies on modern populations with implantable cardioverter-defibrillators (ICDs) are lacking. The UMBRELLA study analyzed the incidence of arrhythmia, device interventions, and mortality in a diverse group of real-world ICD patients with different heart disorders. Results showed that patients with certain heart conditions had higher risks of appropriate ICD therapies, while patients with other conditions had lower risks. Regardless of the cause, contemporary ICD patients with heart failure-related disorders had a similar risk of ICD life-saving interventions and death.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Cardiac & Cardiovascular Systems
Ewa Jedrzejczyk-Patej, Michal Mazurek, Agnieszka Kotalczyk, Wiktoria Kowalska, Aleksandra Konieczny-Kozielska, Jonasz Kozielski, Tomasz Podolecki, Mariola Szulik, Adam Sokal, Oskar Kowalski, Zbigniew Kalarus, Beata Sredniawa, Radoslaw Lenarczyk
Summary: The study compared long-term mortality and predictors in patients with de novo cardiac resynchronization therapy defibrillators (CRT-D) versus those who upgraded from an implantable cardioverter-defibrillator (ICD) to CRT-D. It found that mortality was significantly higher in patients who upgraded from ICD to CRT-D compared to those who had de novo CRT-D implantations, with nearly 45% mortality within 4.5 years. A new CRT scale (Creatinine; Remodelling; Threshold for NYHA) was proposed to aid in predicting survival following CRT upgrade.
Article
Cardiac & Cardiovascular Systems
Gabrielle Norrish, Henry Chubb, Ella Field, Karen McLeod, Maria Ilina, Georgia Spentzou, Jan Till, Piers E. F. Daubeney, Alan Graham Stuart, Jane Matthews, Dominic Hares, Elspeth Brown, Katie Linter, Vinay Bhole, Krishnakumar Pillai, Michael Bowes, Caroline B. Jones, Orhan Uzun, Amos Wong, Arthur Yue, Shankar Sadagopan, Tara Bharucha, Norah Yap, Eric Rosenthal, Sujeev Mathur, Satish Adwani, Zdenka Reinhardt, Jasveer Mangat, Juan Pablo Kaski
Summary: This study analyzed the outcomes of ICD insertion in a national pediatric HCM cohort, finding a high rate of appropriate therapies and some inappropriate therapies. Complications with the devices were also observed in a significant portion of patients, with no predictors for inappropriate therapies or lead complications identified.
Article
Cardiac & Cardiovascular Systems
Satoshi Kawada, Praloy Chakraborty, Lisa Albertini, Abhishek Bhaskaran, Erwin N. Oechslin, Candice Sliversides, Rachel M. Wald, S. Lucy Roche, Louise Harris, Lorna Swan, Rafael Alonso-Gonzalez, Sara Thorne, Eugene Downar, Kumaraswamy Nanthakumar, Blandine Mondesert, Paul Khairy, Krishnakumar Nair
Summary: The study found that right-sided ICD implantation in ACHD patients, although technically challenging with longer procedure time and lower success rate, did not show significant differences in efficacy and complications compared to left-sided ICDs.
CANADIAN JOURNAL OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Victor Nauffal, Peter Marstrand, Larry Han, Victoria N. Parikh, Adam S. Helms, Jodie Ingles, Daniel Jacoby, Neal K. Lakdawala, Sunil Kapur, Michelle Michels, Anjali T. Owens, Euan A. Ashley, Alexandre C. Pereira, Joseph W. Rossano, Sara Saberi, Christopher Semsarian, James S. Ware, Samuel G. Wittekind, Sharlene Day, Iacopo Olivotto, Carolyn Y. Ho
Summary: Primary prevention ICDs are implanted more frequently in US vs. non-US sites across the spectrum of SCD risk. There was a Lower rate of appropriate ICD therapy in US sites, consistent with a lower-risk population, and no significant difference in SCD in US vs. non-US patients who did not receive an ICD.
EUROPEAN HEART JOURNAL
(2021)
Article
Cardiac & Cardiovascular Systems
Mi Kyoung Song, Jae-Sun Uhm, Jae Suk Baek, Ja Kyoung Yoon, Jae Yoon Na, Hee Tae Yu, Ji-Hyuk Yang, Seil Oh, Sang Weon Park, Jinyoung Song, June Huh, Eun-Jung Bae
Summary: A Korean multicenter study found that the utilization rate of ICD therapy in pediatric patients was relatively low, but there was a high rate of appropriate shock occurrence. Efforts are needed to increase the use of ICDs to save the lives of high-risk patients and reduce the incidence of inappropriate shocks.
CIRCULATION JOURNAL
(2021)
Review
Cardiac & Cardiovascular Systems
Nso Nso, Mahmoud Nassar, Sofia Lakhdar, Sostanie Enoru, Laura Guzman, Vincent Rizzo, Most S. Munira, Farshid Radparvar, Senthil Thambidorai
Summary: Based on the updated evidence, subcutaneous implantable cardioverter-defibrillator (S-ICD) is safer and more effective than transvenous implantable cardioverter-defibrillator (TV-ICD) as it reduces the incidence of pocket complications, lead displacement or fracture, inappropriate sensing, defibrillation lead failure, pneumothorax/hemothorax, device failure, lead erosion, and all-cause mortality.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Marit van Barreveld, Tom E. Verstraelen, Pascal F. H. M. van Dessel, Lucas V. A. Boersma, Peter Paul H. M. Delnoy, Anton E. Tuinenburg, Dominic A. M. J. Theuns, Pepijn H. van der Voort, Geert-Jan Kimman, Erik Buskens, Aeilko H. Zwinderman, Arthur A. M. Wilde, Marcel G. W. Dijkgraaf
Summary: This study in a Dutch cohort of implantable cardioverter-defibrillator patients found that 13.6% experienced complications, with 7.8% being major complications. Lead-related issues and infections were the most common. Stricter implant indication criteria could potentially reduce complications.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Cardiac & Cardiovascular Systems
Federico Migliore, Raimondo Pittorru, Manuel De Lazzari, Alberto Cipriani, Barbara Bauce, Martina Perazzolo Marra, Enrico Giacomin, Pietro Bernardo Dall'Aglio, Stefano Accinelli, Sabino Iliceto, Domenico Corrado
Summary: This study evaluated the long-term outcome of patients with arrhyth-mogenic cardiomyopathy (ACM) who underwent third-generation subcutaneous implantable cardioverter defibrillator (S-ICD) implantation with the intermuscular (IM) two-incision technique. The findings showed that although the third-generation S-ICD with the IM two-incision technique appeared to have a low risk of complications and inappropriate shocks (IS) due to cardiac oversensing, the risk of IS due to myopotential mainly during effort should be considered.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2023)